Valuation: Illumina, Inc.

Market Cap 41.04B 36.9B 34.43B 31.21B 58.59B 3,905B 58.95B 413B 161B 2,027B 154B 151B 6,519B P/E 2026 *
54.9x
P/E 2027 * 45.8x
Enterprise Value 41B 36.86B 34.4B 31.18B 58.53B 3,901B 58.9B 413B 161B 2,025B 154B 151B 6,512B EV / Sales 2026 *
8.87x
EV / Sales 2027 * 8.12x
Free-Float
74.97%
Yield 2026 *
-
Yield 2027 * -
1 day+0.22%
1 week+1.49%
Current month-0.70%
1 month+30.52%
3 months+42.13%
6 months+108.53%
Current year+107.20%
1 week 265.25
Extreme 265.25
278.59
1 month 223.7
Extreme 223.7
309.34
Current year 112.65
Extreme 112.65
309.34
1 year 93.5
Extreme 93.5
309.34
3 years 68.7
Extreme 68.7
309.34
5 years 68.7
Extreme 68.7
428
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
10/5/26 A Tax

Chief Executive Officer

-1,303 0.0009%
9/30/26 A
Corvex Management LP
OtherCompany 0 0% -
9/30/26 A Free

Director

113 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.22%+1.49%+198.64%+110.49% 41.04B
+1.53%+1.68%+28.03%+39.42% 249B
+0.83%+2.84%+8.99%+7.29% 158B
-0.43%+1.38%-3.70%+53.85% 148B
-0.72%+3.42%-55.32%-13.17% 62.32B
+0.38%+3.92%-13.68%-15.68% 49.61B
+1.38%+0.78%+17.84%+22.14% 49.83B
-1.42%+5.26%+3.37%+37.59% 48.14B
+1.40%+2.90%+26.05%+57.45% 49.06B
+1.73%+0.14%+31.06%+72.84% 42.9B
Average +0.49%+1.90%+24.13%+37.22% 89.82B
Weighted average by Cap. +0.64%+1.82%+17.29%+34.23%

Financials

2026 *2027 *
Net sales 4.62B 4.16B 3.88B 3.52B 6.6B 440B 6.64B 46.57B 18.18B 228B 17.36B 16.99B 735B 4.92B 4.43B 4.13B 3.74B 7.03B 469B 7.07B 49.57B 19.36B 243B 18.48B 18.08B 782B
Net income 773M 695M 648M 588M 1.1B 73.54B 1.11B 7.78B 3.04B 38.17B 2.9B 2.84B 123B 912M 820M 765M 694M 1.3B 86.8B 1.31B 9.18B 3.59B 45.05B 3.42B 3.35B 145B
Net Debt -38.82M -34.91M -32.58M -29.52M -55.43M -3.69B -55.77M -391M -153M -1.92B -146M -143M -6.17B -1.05B -943M -880M -797M -1.5B -99.76B -1.51B -10.56B -4.12B -51.78B -3.94B -3.85B -167B
Projected Income Statement - Annual - Illumina, Inc.
Logo Illumina, Inc.
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (85.4%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (14.6%). Net sales are distributed geographically as follows: the United States (51.6%), Americas (3.8%), Europe (29.1%), Asia/Pacific/Middle East/Africa (9.9%) and China/Taiwan/Hong Kong (5.6%).
Employees
8,625
Date Price Change Volume
14/10/26 $271.76 +0.22% 2,120,760
13/10/26 $271.18 -1.99% 1,893,800
12/10/26 $276.67 -0.54% 1,643,000
09/10/26 $278.17 +5.14% 1,895,816
08/10/26 $264.57 -1.19% 3,169,783
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Illumina, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
271.76USD
Average target price
241.05USD
Spread / Average Target
-11.30%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Illumina, Inc.
  1. Stock Market
  2. Stocks
  3. ILMN Stock